Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy

Michelle Wehling-Henricks, Zhenzhi Li, Catherine Lindsey, Ying Wang, Steven S. Welc, Julian N. Ramos, Négar Khanlou, Makoto Kuro-O, James G. Tidball

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Duchenne muscular dystrophy (DMD) is a lethal muscle disease involving progressive loss of muscle regenerative capacity and increased fibrosis. We tested whether epigenetic silencing of the klotho gene occurs in the mdx mouse model of DMD and whether klotho silencing is an important feature of the disease. Our findings show that klotho undergoes muscle-specific silencing at the acute onset of mdx pathology. Klotho experiences increased methylation of CpG sites in its promoter region, which is associated with gene silencing, and increases in a repressive histone mark, H3K9me2. Expression of a klotho transgene in mdx mice restored their longevity, reduced muscle wasting, improved function and greatly increased the pool of muscle-resident stem cells required for regeneration. Reductions of fibrosis in late, progressive stages of the mdx pathology achieved by transgene expression were paralleled by reduced expression of Wnt target genes (axin-2), transforming growth factor-beta (TGF-β1) and collagens types 1 and 3, indicating that Klotho inhibition of the profibrotic Wnt/TGFβ axis underlies its anti-fibrotic effect in aging, dystrophic muscle. Thus, epigenetic silencing of klotho during muscular dystrophy contributes substantially to lost regenerative capacity and increased fibrosis of dystrophic muscle during late progressive stages of the disease.

Original languageEnglish (US)
Pages (from-to)2465-2482
Number of pages18
JournalHuman Molecular Genetics
Volume25
Issue number12
StatePublished - Jun 15 2016

Fingerprint

Inbred mdx Mouse
Duchenne Muscular Dystrophy
Gene Silencing
Pathology
Muscles
Fibrosis
Collagen Type I
Transgenes
Epigenomics
Histone Code
Muscular Dystrophies
Genetic Promoter Regions
Transforming Growth Factor beta
Methylation
Regeneration
Stem Cells

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Wehling-Henricks, M., Li, Z., Lindsey, C., Wang, Y., Welc, S. S., Ramos, J. N., ... Tidball, J. G. (2016). Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy. Human Molecular Genetics, 25(12), 2465-2482.

Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy. / Wehling-Henricks, Michelle; Li, Zhenzhi; Lindsey, Catherine; Wang, Ying; Welc, Steven S.; Ramos, Julian N.; Khanlou, Négar; Kuro-O, Makoto; Tidball, James G.

In: Human Molecular Genetics, Vol. 25, No. 12, 15.06.2016, p. 2465-2482.

Research output: Contribution to journalArticle

Wehling-Henricks, M, Li, Z, Lindsey, C, Wang, Y, Welc, SS, Ramos, JN, Khanlou, N, Kuro-O, M & Tidball, JG 2016, 'Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy', Human Molecular Genetics, vol. 25, no. 12, pp. 2465-2482.
Wehling-Henricks M, Li Z, Lindsey C, Wang Y, Welc SS, Ramos JN et al. Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy. Human Molecular Genetics. 2016 Jun 15;25(12):2465-2482.
Wehling-Henricks, Michelle ; Li, Zhenzhi ; Lindsey, Catherine ; Wang, Ying ; Welc, Steven S. ; Ramos, Julian N. ; Khanlou, Négar ; Kuro-O, Makoto ; Tidball, James G. / Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy. In: Human Molecular Genetics. 2016 ; Vol. 25, No. 12. pp. 2465-2482.
@article{621cceca47324269862995a313b19963,
title = "Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy",
abstract = "Duchenne muscular dystrophy (DMD) is a lethal muscle disease involving progressive loss of muscle regenerative capacity and increased fibrosis. We tested whether epigenetic silencing of the klotho gene occurs in the mdx mouse model of DMD and whether klotho silencing is an important feature of the disease. Our findings show that klotho undergoes muscle-specific silencing at the acute onset of mdx pathology. Klotho experiences increased methylation of CpG sites in its promoter region, which is associated with gene silencing, and increases in a repressive histone mark, H3K9me2. Expression of a klotho transgene in mdx mice restored their longevity, reduced muscle wasting, improved function and greatly increased the pool of muscle-resident stem cells required for regeneration. Reductions of fibrosis in late, progressive stages of the mdx pathology achieved by transgene expression were paralleled by reduced expression of Wnt target genes (axin-2), transforming growth factor-beta (TGF-β1) and collagens types 1 and 3, indicating that Klotho inhibition of the profibrotic Wnt/TGFβ axis underlies its anti-fibrotic effect in aging, dystrophic muscle. Thus, epigenetic silencing of klotho during muscular dystrophy contributes substantially to lost regenerative capacity and increased fibrosis of dystrophic muscle during late progressive stages of the disease.",
author = "Michelle Wehling-Henricks and Zhenzhi Li and Catherine Lindsey and Ying Wang and Welc, {Steven S.} and Ramos, {Julian N.} and N{\'e}gar Khanlou and Makoto Kuro-O and Tidball, {James G.}",
year = "2016",
month = "6",
day = "15",
language = "English (US)",
volume = "25",
pages = "2465--2482",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy

AU - Wehling-Henricks, Michelle

AU - Li, Zhenzhi

AU - Lindsey, Catherine

AU - Wang, Ying

AU - Welc, Steven S.

AU - Ramos, Julian N.

AU - Khanlou, Négar

AU - Kuro-O, Makoto

AU - Tidball, James G.

PY - 2016/6/15

Y1 - 2016/6/15

N2 - Duchenne muscular dystrophy (DMD) is a lethal muscle disease involving progressive loss of muscle regenerative capacity and increased fibrosis. We tested whether epigenetic silencing of the klotho gene occurs in the mdx mouse model of DMD and whether klotho silencing is an important feature of the disease. Our findings show that klotho undergoes muscle-specific silencing at the acute onset of mdx pathology. Klotho experiences increased methylation of CpG sites in its promoter region, which is associated with gene silencing, and increases in a repressive histone mark, H3K9me2. Expression of a klotho transgene in mdx mice restored their longevity, reduced muscle wasting, improved function and greatly increased the pool of muscle-resident stem cells required for regeneration. Reductions of fibrosis in late, progressive stages of the mdx pathology achieved by transgene expression were paralleled by reduced expression of Wnt target genes (axin-2), transforming growth factor-beta (TGF-β1) and collagens types 1 and 3, indicating that Klotho inhibition of the profibrotic Wnt/TGFβ axis underlies its anti-fibrotic effect in aging, dystrophic muscle. Thus, epigenetic silencing of klotho during muscular dystrophy contributes substantially to lost regenerative capacity and increased fibrosis of dystrophic muscle during late progressive stages of the disease.

AB - Duchenne muscular dystrophy (DMD) is a lethal muscle disease involving progressive loss of muscle regenerative capacity and increased fibrosis. We tested whether epigenetic silencing of the klotho gene occurs in the mdx mouse model of DMD and whether klotho silencing is an important feature of the disease. Our findings show that klotho undergoes muscle-specific silencing at the acute onset of mdx pathology. Klotho experiences increased methylation of CpG sites in its promoter region, which is associated with gene silencing, and increases in a repressive histone mark, H3K9me2. Expression of a klotho transgene in mdx mice restored their longevity, reduced muscle wasting, improved function and greatly increased the pool of muscle-resident stem cells required for regeneration. Reductions of fibrosis in late, progressive stages of the mdx pathology achieved by transgene expression were paralleled by reduced expression of Wnt target genes (axin-2), transforming growth factor-beta (TGF-β1) and collagens types 1 and 3, indicating that Klotho inhibition of the profibrotic Wnt/TGFβ axis underlies its anti-fibrotic effect in aging, dystrophic muscle. Thus, epigenetic silencing of klotho during muscular dystrophy contributes substantially to lost regenerative capacity and increased fibrosis of dystrophic muscle during late progressive stages of the disease.

UR - http://www.scopus.com/inward/record.url?scp=84999548310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84999548310&partnerID=8YFLogxK

M3 - Article

C2 - 27154199

AN - SCOPUS:84999548310

VL - 25

SP - 2465

EP - 2482

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 12

ER -